AMARILLO BIOSCIENCES INC has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1998. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are NEXMED HOLDINGS INC, SHIRE LAB INC and HEALTH MAINTENANCE PROGRAMS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Taiwan | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Medical technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Microorganisms | |
#5 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Cummins Joseph M | 11 |
#2 | Cummins Martin Joseph | 9 |
#3 | Richards Alan B | 6 |
#4 | Sherwood Edward | 6 |
#5 | Amento Edward P | 4 |
#6 | Lee Ching-Yuan | 4 |
#7 | Cummins Joseph Mont | 4 |
#8 | Yeh Chau-Ting | 4 |
#9 | Fox Philip Caplan | 3 |
#10 | Smith Kelly J | 3 |
Publication | Filing date | Title |
---|---|---|
US2021113777A1 | Smart drug injection device | |
US2015132261A1 | Treatment of thrombocytopenia using orally administered interferon | |
WO2009152152A1 | Treatment of obesity with an interferon | |
WO2008036747A2 | Composition and method for immunomodulation | |
US2007237723A1 | Treatment of cough with interferon | |
WO0174396A1 | Composition and method for promoting oral health | |
AU7731700A | Low dose ifn-gamma for treatment of disease | |
AU2031800A | Interferon-alpha mediated upregulation of aquaporin expression | |
US6036949A | Treatment of fibromyalgia with low doses of interferon |